Sugar coating extends half-lives and improves effectiveness of cytokine hormones
Author:
- 1 November 2003
- journal article
- review article
- Published by Elsevier in Trends in Biotechnology
- Vol. 21 (11) , 462-464
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Enhancement of therapeutic protein in vivo activities through glycoengineeringNature Biotechnology, 2003
- The enigma of the metabolic fate of circulating erythropoietin (Epo) in view of the pharmacokinetics of the recombinant drugs rhEpo and NESPEuropean Journal of Haematology, 2002
- Sugar profiling proves that human serum erythropoietin differs from recombinant human erythropoietinBlood, 2001
- Development and characterization of novel erythropoiesis stimulating protein (NESP)British Journal of Cancer, 2001
- Regulation of expression of the erythropoietin geneCurrent Opinion in Hematology, 1998
- General Classes and Functions of Four-Helix Bundle Cytokines1998
- Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptorCell, 1995
- Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: a mechanism for controlled rates of erythrocyte productionBlood, 1993
- Erythropoietin Retards DNA Breakdown and Prevents Programmed Death in Erythroid Progenitor CellsScience, 1990
- Characterization of recombinant human erythropoietin produced in Chinese hamster ovary cellsBiochemistry, 1987